These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins. Alexyuk PG; Bogoyavlenskiy AP; Alexyuk MS; Turmagambetova AS; Zaitseva IA; Omirtaeva ES; Berezin VE Arch Virol; 2019 Jul; 164(7):1793-1803. PubMed ID: 31079211 [TBL] [Abstract][Full Text] [Related]
3. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms. Behboudi S; Morein B; Rönnberg B Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of immunostimulating complexes (ISCOMs) of Japanese encephalitis virus. Yeolekar LR; Banerjee K Vaccine; 1996 Nov; 14(16):1553-9. PubMed ID: 9014299 [TBL] [Abstract][Full Text] [Related]
5. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix. Fossum C; Bergström M; Lövgren K; Watson DL; Morein B Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899 [TBL] [Abstract][Full Text] [Related]
6. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines. Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A. Kamstrup S; San Martin R; Doberti A; Grande H; Dalsgaard K Vaccine; 2000 Apr; 18(21):2244-9. PubMed ID: 10717344 [TBL] [Abstract][Full Text] [Related]
11. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components. Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782 [TBL] [Abstract][Full Text] [Related]
12. Iscoms with different quillaja saponin components differ in their immunomodulating activities. Johansson M; Lövgren-Bengtsson K Vaccine; 1999 Jul; 17(22):2894-900. PubMed ID: 10438061 [TBL] [Abstract][Full Text] [Related]
15. Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines. Dalsgaard K Arch Gesamte Virusforsch; 1974; 44(3):243-54. PubMed ID: 4365900 [No Abstract] [Full Text] [Related]
16. ISCOMs and ISCOMATRIX. Sun HX; Xie Y; Ye YP Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632 [TBL] [Abstract][Full Text] [Related]
17. On the structure of immune-stimulating saponin-lipid complexes (iscoms). Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of the immune response by immunization with antigens in defined multimeric physical forms. Morein B Vet Immunol Immunopathol; 1987 Dec; 17(1-4):153-9. PubMed ID: 3124333 [TBL] [Abstract][Full Text] [Related]
19. Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina. Gilabert-Oriol R; Weng A; von Mallinckrodt B; Stöshel A; Nissi L; Melzig MF; Fuchs H; Thakur M Int J Pharm; 2015 Jun; 487(1-2):39-48. PubMed ID: 25839418 [TBL] [Abstract][Full Text] [Related]
20. [Enhancing the immunogenic activity of influvac vaccine in the use of adjuvant TI complexes modified by echinochrome A]. Tsybul'skiĭ AV; Popov AM; Artiukov AA; Mazeĭka AN; Kostetskiĭ É; Sanina NM; Krivoshapko ON Vopr Virusol; 2012; 57(2):23-7. PubMed ID: 22834143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]